From Name:
From Email:
To Name:
To Email:

Optional Message:


FDA approves first drug for spinal muscular atrophy

from FDA.gov

The U.S. Food and Drug Administration today approved Spinraza, the first drug approved to treat children and adults with spinal muscular atrophy, a rare and often fatal genetic disease affecting muscle strength and movement. Spinraza is an injection administered into the fluid surrounding the spinal cord. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063